Leanna R. Miller, RN, MN, CCRN-CSC, PCCN-CMC, CNRN, CEN, NP Education Specialist LRM Consulting Nashville, TN.

Slides:



Advertisements
Similar presentations
Coagulopathy and blood component transfusion in trauma
Advertisements

Hemostasis Shaina Eckhouse 10/12/2010.
1. What is the sequence of the intrinsic pathway of coagulation?
Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN.
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
Bleeding disorders Doc. MUDr. L. Boudová, Ph.D.. Bleeding disorders I. Vessels - increased fragility II. Platelets - deficiency or dysfunction III.Coagulation.
Disseminated Intravascular Coagulation
 An acquired syndrome characterized by systemic intravascular coagulation  Coagulation is always the initial event.  Most morbidity and mortality depends.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
OUTLINE: I.Historical Perspective. A. Development of Thromboelastography. B. The expansion and transition from Cardiac Surgery to Trauma. II.Traditional.
Massive Transfusion Mary Jo Drew, MD, MHSA Chief Medical Officer Pacific Northwest Blood Services Region.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
Bleeding time,clotting time, PT, and PTT
Disseminated intravascular coagulation (DIC)
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
DIC Disseminated intravascular coagulation
Hemostasis and Blood Coagulation
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
The Effects of CPB Brian Schwartz, CCP November 5, 2002.
Bleeding Disorders Dr. Farjah H.AlGahtani
Basic Clinician Training Module 3
Approach to Bleeding Disorders
Dr Ahmed abdulwahab. Hemorrhage is still one of the leading cause of maternal mortality all over the world DEFINITION Primary post partum hemorrhage.
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
Disseminated intravascular coagulation
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
Hemostasis. Hemostasis Definition Prevention of blood loss (stoppage of blood flow)
DIC disseminated intravascular coagulation DIC is characterized by widespread coagulation and bleeding in the vascular compartment. DIC begins with massive.
Disseminated Intravascular Coagulation (DIC) 【 Change of basic pathology 】 【 Change of basic pathology 】 Key change Key change This fine homeostatic.
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
Basic Clinician Training Module 6
Hemodynamics, Thromboembolism and Shock Review with Animations Nicole L. Draper, MD.
The Clotting Cascade and DIC Karim Rafaat, MD. Coagulation Coagulation is a host defense system that maintains the integrity of the high pressure closed.
ASSOCIATE PROFESSOR IOLANDA BLIDARU MD, PhD.
Investigation of Haemostasis MS. c. program Lab-9.
Fibrinolysis and Hyperfibrinolysis TEG Analysis
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Topics in Coagulation Donald M. Voltz, M.D. Assistant Professor of Anesthesiology Case Western Reserve University / University Hospitals of Cleveland.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
Hemostasis and Coagulation Hemostasis Hemostasis is the maintenance of circulating blood in the liquid state and retention of blood in the vascular system.
Coagulopathy in Trauma Seunghwan Kim, M.D. Dept. of Emergency Medicine College of Medicine, Yonsei University.
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi* Academic Medical Center, University of Amsterdam,
Chapter 23. Bleeding disorders associated with coagulopathy
Systemic anticoagulation during ECMO is intended to control thrombin generation and limit the risk for thrombotic and hemorrhagic complications.
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
IN THE NAME OF GOD Disseminated Intravascular Coagulation Dr.h-kayalhaAnesthesiologist.
Bleeding disorders due to vascular & platelets abnormalities
Multiple choice questions
Hematologic Emergencies
Immune thrombocytopenia purpura(ITP)
General Principles of Hemostasis Kristine Krafts, M.D.
Bleeding disorders Dr. Feras FARARJEH.
Disseminated Intravascular Coagulation
Coagulation Cascade of the Newborn
Disseminated Intravascular Coagulation
Coagulation Disorders Importance in surgical practice
Bleeding disorders Dr. Feras FARARJEH.
Disseminated intravascular coagulation (DIC)
General Principles of Hemostasis Kristine Krafts, M.D.
Hemostasis and Coagulation
Presentation transcript:

Leanna R. Miller, RN, MN, CCRN-CSC, PCCN-CMC, CNRN, CEN, NP Education Specialist LRM Consulting Nashville, TN

 Objectives  Identify the most likely type of coagulopathy with regards to INR, aPTT, platelet numbers and function.  Discuss the four causes of thrombocytopenia.  Describe the priorities in the management of patients with life – threatening coagulopathies.

Admission Screening identify defects in hemostasis that can be corrected guide the management of hemostatic defects that cannot be corrected help manage the bleeding that cannot be prevented

Preoperative Screening History & Physical unlikely congenital or familial coagulopathy –no personal or family history of bleeding –no abnormal bleeding associated with: dental extractions previous surgery routine childhood trauma

Preoperative Screening CBC –  Hgb/Hct –  platelets PT/PTT Bleeding Time

Admission Screening Assessment of Coagulopathy –CBC with coagulation studies –check for and correct hypothermia –review the history –review medications

SymptomINRaPTTPlatelet #Platelet Function HistoryDiagnosis Major/minor bleeding NN  N Massive transfusion; fluids Dilutional thrombocytopenia Major/minor bleeding N Prolonged NN negativeDrug induced - heparin Major/minor bleeding  NNn/a Vitamin K deficiency Liver disease, warfarin, antibiotics Major bleeding prolonged  N DIC

Postoperative Bleeding Vascular integrity disruption –reoperation

Medical Causes of Bleeding residual heparin effect platelet consumption (CPB) preoperative platelet inactivation

Protamine Reactions Type I –benign reaction –Histamine release  systemic hypotension –administer protamine slowly

Protamine Reactions Type II –anaphylactoid reaction –occurs within 10 to 20 minutes of administration –symptoms hypotension flushing edema bronchospasm

Protamine Reactions Type III –catastrophic pulmonary vasoconstriction elevated pulmonary pressures cardiopulmonary collapse noncardiogenic pulmonary edema –reaction occurs between 10 to 20 minutes after start of administration

Medical Causes of Bleeding depletion of clotting factors pre-existing coagulopathy fibrinolysis

Thrombocytopenia –  platelet destruction drug – induced DIC

Differential diagnosis A platelet count fall that begins 5 to 10 days after cardiac surgery or that occurs abruptly after starting heparin in a patient previously exposed to heparin within the past 5 to 100 days, is very suggestive of HIT.

Thrombocytopenia –Etiology abnormal distribution or sequestration in spleen –portal hypertension

Thrombocytopenia –Etiology dilutional after hemorrhage, RBC transfusions

Thrombocytopenia –Diagnosis  hemoglobin,hematocrit, platelets prolonged bleeding time, PT, PTT

Definition serious bleeding disorder thrombosis; then hemorrhage Disseminated Intravascular Coagulation

Pathophysiology Intrinsic Clotting Cascade –endothelial injury –assessed by PTT

Pathophysiology Extrinsic Clotting Cascade –tissue thromboplastin –assessed by PT

Etiology of DIC Obstetric –abruptio placentae –amniotic fluid embolus –eclampsia

Etiology of DIC Hemolytic/Immunologic –anaphylaxis –hemolytic blood reaction –massive blood transfusion

Etiology of DIC Infectious –bacterial –fungal –viral –rickettsial

Etiology of DIC Vascular –shock –dissecting aneurysm

Etiology of DIC Miscellaneous –Emboli (fat) –ASA poisoning –GI disturbances - pancreatitis

Laboratory Findings  platelets  fibrinogen  PT &/or PTT  d - dimer or FSP  ATIII

Management Treat underlying cause –surgery –antimicrobials –antineoplastics

Management Stop Thrombosis –IV heparin –AT III –plasmapheresis

Management Administer blood products –pRBCs –platelets –FFP –cryoprecipitate

Complications hypovolemic shock acute renal failure infection ARDS

Postoperative Bleeding Platelet Dysfunction –Platelets –FFP/cryoprecipitate –DDAVP

Postoperative Bleeding Coagulation Factor Deficiency –FFP/cryoprecipitate –protamine

Postoperative Bleeding Hyperfibrinolysis –DDAVP –Antifibrinolytics Amicar

Case Study 62 – year old male admitted to CVICU post bypass complications postop (tamponade) – stabilized & on IABP required CPR several times

Case Study 3 days later diminished leg circulation – IABP removed pneumonia, groin infection, renal failure step – down develops sternal wound infection

Lab Values ABGs pH7.26 pO 2 55 pCO 2 52 HCO 3 18 SaO 2 84%

CV Status BP 88/56 MAP 67 CVP 4 ECG ST T 39.2°C

Case Study Hgb/Hct 8.8 / 30% PT38 seconds Fibrinogen 102 mg/dL Platelets 50,000/mm 3 D – dimer > 2500 ng/dL FSP 80 mcg/dL

IN CONCLUSION